Detalhe da pesquisa
1.
Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case-control study.
PLoS Med
; 20(1): e1004156, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630477
2.
Vaccine coverage and effectiveness against laboratory-confirmed symptomatic and severe Covid-19 in indigenous people in Brazil: a cohort study.
BMC Public Health
; 23(1): 1267, 2023 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386490
3.
CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study.
BMC Med
; 20(1): 146, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35379250
4.
Transient Hearing Loss in Adults Associated With Zika Virus Infection.
Clin Infect Dis
; 64(5): 675-677, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27927858
5.
Arginase I, polyamine, and prostaglandin E2 pathways suppress the inflammatory response and contribute to diffuse cutaneous leishmaniasis.
J Infect Dis
; 211(3): 426-35, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25124926
6.
Risk of death following chikungunya virus disease in the 100 Million Brazilian Cohort, 2015-18: a matched cohort study and self-controlled case series.
Lancet Infect Dis
; 24(5): 504-513, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38342106
7.
Pathophysiology of chikungunya virus infection associated with fatal outcomes.
Cell Host Microbe
; 32(4): 606-622.e8, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38479396
8.
Syndromic Surveillance Using Structured Telehealth Data: Case Study of the First Wave of COVID-19 in Brazil.
JMIR Public Health Surveill
; 9: e40036, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692925
9.
Early detection of respiratory disease outbreaks through primary healthcare data.
J Glob Health
; 13: 04124, 2023 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37917874
10.
Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group.
J Glob Health
; 13: 06015, 2023 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37166260
11.
Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil.
Nat Commun
; 13(1): 4154, 2022 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35851597
12.
Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study.
Lancet Reg Health Am
; 6: 100154, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34957437
13.
Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil.
Nat Med
; 28(4): 838-843, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35140406
14.
Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study.
Lancet Infect Dis
; 22(11): 1577-1586, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35952702
15.
Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study.
Lancet Infect Dis
; 22(6): 791-801, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35366959
16.
SARS-CoV-2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: A serial cross-sectional study.
Elife
; 112022 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36135358
17.
Human mucosal leishmaniasis: neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines.
Eur J Immunol
; 40(10): 2830-6, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20812234
18.
The Long Pentraxin 3 (PTX3) Suppresses Immunity to Cutaneous Leishmaniasis by Regulating CD4+ T Helper Cell Response.
Cell Rep
; 33(11): 108513, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33326783
19.
The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era.
Lancet Infect Dis
; 23(5): 511-512, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681085
20.
Effectiveness of monovalent and bivalent COVID-19 vaccines.
Lancet Infect Dis
; 23(11): 1208-1209, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37453442